Robert Guttendorf

A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease

Michael Grundman, Roger Morgan, Jason D. Lickliter et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 106 citations · Full text

HIV Protease Inhibitors Possessing a Novel, High-Affinity, and Achiral P1'/P2' Ligand with a Unique Pattern of in Vitro Resistance. Importance of a Conformationally-Restricted Template in the Design of Enzyme Inhibitors

J. V. N. Vara Prasad, Elizabeth A. Lunney, Donna Ferguson et al. · Journal of the American Chemical Society · 1995 · 30 citations

Altmetric Attention Score, Molecular Biology, Peptide Science +19

Simplified Phenotyping with Dextromethorphan by Thin-Layer Chromatography

Robert Guttendorf, Peter J. Wedlund, J. W. Blake et al. · Therapeutic Drug Monitoring · 1988 · 26 citations

Biochemistry, Gas Chromatography, Medicine +15

Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to <i>Streptococcus pyogenes</i> in Children

Michael E. Pichichero, Joseph R. Casey, Stan L. Block et al. · Antimicrobial Agents and Chemotherapy · 2008 · 25 citations · Full text

Tracheobronchitis, Penicillin Vk Suspension, Health Sciences +15

Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

CF Nagy, John Mondick, Natalya V. Serbina et al. · Clinical and Translational Science · 2016 · 24 citations · Full text